Metabolic re-wiring of isogenic breast epithelial cell lines following epithelial to mesenchymal transition

Abstract Epithelial to mesenchymal transition (EMT) has implications in tumor progression and metastasis. Metabolic alterations have been described in cancer development but studies focused on the metabolic re-wiring that takes place during EMT are still limited. We performed metabolomics profiling...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer letters 2017-06, Vol.396, p.117-129
Hauptverfasser: Halldorsson, Skarphedinn, Rohatgi, Neha, Magnusdottir, Manuela, Choudhary, Kumari Sonal, Guðjónsson, Thorarinn, Knutsen, Erik, Barkovskaya, Anna, Hilmarsdottir, Bylgja, Perander, Maria, Mælandsmo, Gunhild M, Gudmundsson, Steinn, Rolfsson, Óttar
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 129
container_issue
container_start_page 117
container_title Cancer letters
container_volume 396
creator Halldorsson, Skarphedinn
Rohatgi, Neha
Magnusdottir, Manuela
Choudhary, Kumari Sonal
Guðjónsson, Thorarinn
Knutsen, Erik
Barkovskaya, Anna
Hilmarsdottir, Bylgja
Perander, Maria
Mælandsmo, Gunhild M
Gudmundsson, Steinn
Rolfsson, Óttar
description Abstract Epithelial to mesenchymal transition (EMT) has implications in tumor progression and metastasis. Metabolic alterations have been described in cancer development but studies focused on the metabolic re-wiring that takes place during EMT are still limited. We performed metabolomics profiling of a breast epithelial cell line and its EMT derived mesenchymal phenotype to create genome-scale metabolic models descriptive of both cell lines. Glycolysis and OXPHOS were higher in the epithelial phenotype while amino acid anaplerosis and fatty acid oxidation fueled the mesenchymal phenotype. Through comparative bioinformatics analysis, PPAR-γ1, PPAR- γ2 and AP-1 were found to be the most influential transcription factors associated with metabolic re-wiring. In silico gene essentiality analysis predicts that the LAT1 neutral amino acid transporter is essential for mesenchymal cell survival. Our results define metabolic traits that distinguish an EMT derived mesenchymal cell line from its epithelial progenitor and may have implications in cancer progression and metastasis. Furthermore, the tools presented here can aid in identifying critical metabolic nodes that may serve as therapeutic targets aiming to prevent EMT and inhibit metastatic dissemination.
doi_str_mv 10.1016/j.canlet.2017.03.019
format Article
fullrecord <record><control><sourceid>proquest_crist</sourceid><recordid>TN_cdi_cristin_nora_10037_13480</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0304383517301830</els_id><sourcerecordid>1888122749</sourcerecordid><originalsourceid>FETCH-LOGICAL-c581t-870fdb70165f5c2d79db01b7667cacc8bf63e1747a4978784ab9658f6292865a3</originalsourceid><addsrcrecordid>eNqFksFu1DAQhi0EotvCGyCIxIVLwthOYueChCooSEUcgLPlOJPWW8debC_Vvj2OtgXUCyfL9jfzz8w_hLyg0FCg_dttY7R3mBsGVDTAG6DDI7KhUrBaDBIekw1waGsueXdCTlPaAkDXiu4pOWGSMw6cbcjNF8x6DM6aKmJ9a6P1V1WYK5vCFfryOkbUKVe4s_kandWuMuhc5azHVM3BuXC7hvzzn0O1YEJvrg_Leo3aJ5tt8M_Ik1m7hM_vzjPy4-OH7-ef6suvF5_P31_WppM011LAPI2i9NjNnWGTGKYR6Cj6XhhtjBznniMVrdDtIKSQrR6HvpNzzwYm-07zM_LqmNdEm7L1yoeoFQXgQlHeSijEmyOxi-HnHlNWi01rX9pj2CdVhjj0PeUdL-jrB-g27KMv9RdKSsqYaIdCtfeSIaWIs9pFu-h4KLJqtUtt1dEutdqlgKtiVwl7eZd8Py44_Qm696cA744Alnn9shhVMraMFicb0WQ1Bfs_hYcJTLHOGu1u8IDpby8qMQXq27oy68ZQwYHKUsNvhui7yg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1888122749</pqid></control><display><type>article</type><title>Metabolic re-wiring of isogenic breast epithelial cell lines following epithelial to mesenchymal transition</title><source>MEDLINE</source><source>NORA - Norwegian Open Research Archives</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Halldorsson, Skarphedinn ; Rohatgi, Neha ; Magnusdottir, Manuela ; Choudhary, Kumari Sonal ; Guðjónsson, Thorarinn ; Knutsen, Erik ; Barkovskaya, Anna ; Hilmarsdottir, Bylgja ; Perander, Maria ; Mælandsmo, Gunhild M ; Gudmundsson, Steinn ; Rolfsson, Óttar</creator><creatorcontrib>Halldorsson, Skarphedinn ; Rohatgi, Neha ; Magnusdottir, Manuela ; Choudhary, Kumari Sonal ; Guðjónsson, Thorarinn ; Knutsen, Erik ; Barkovskaya, Anna ; Hilmarsdottir, Bylgja ; Perander, Maria ; Mælandsmo, Gunhild M ; Gudmundsson, Steinn ; Rolfsson, Óttar</creatorcontrib><description>Abstract Epithelial to mesenchymal transition (EMT) has implications in tumor progression and metastasis. Metabolic alterations have been described in cancer development but studies focused on the metabolic re-wiring that takes place during EMT are still limited. We performed metabolomics profiling of a breast epithelial cell line and its EMT derived mesenchymal phenotype to create genome-scale metabolic models descriptive of both cell lines. Glycolysis and OXPHOS were higher in the epithelial phenotype while amino acid anaplerosis and fatty acid oxidation fueled the mesenchymal phenotype. Through comparative bioinformatics analysis, PPAR-γ1, PPAR- γ2 and AP-1 were found to be the most influential transcription factors associated with metabolic re-wiring. In silico gene essentiality analysis predicts that the LAT1 neutral amino acid transporter is essential for mesenchymal cell survival. Our results define metabolic traits that distinguish an EMT derived mesenchymal cell line from its epithelial progenitor and may have implications in cancer progression and metastasis. Furthermore, the tools presented here can aid in identifying critical metabolic nodes that may serve as therapeutic targets aiming to prevent EMT and inhibit metastatic dissemination.</description><identifier>ISSN: 0304-3835</identifier><identifier>ISSN: 1872-7980</identifier><identifier>EISSN: 1872-7980</identifier><identifier>DOI: 10.1016/j.canlet.2017.03.019</identifier><identifier>PMID: 28323032</identifier><language>eng</language><publisher>Ireland: Elsevier B.V</publisher><subject>Activator protein 1 ; Amino acids ; Bioinformatics ; Biomarkers ; Breast - metabolism ; Breast - pathology ; Breast cancer ; Breast Neoplasms - genetics ; Breast Neoplasms - metabolism ; Breast Neoplasms - pathology ; Cancer ; Cell adhesion &amp; migration ; Cell culture ; Cell survival ; Clinical medical disciplines: 750 ; EMT ; Epithelial Cells - metabolism ; Epithelial Cells - pathology ; Epithelial-Mesenchymal Transition ; Female ; Genome scale models ; Genomes ; Genotype &amp; phenotype ; Glycolysis ; Hematology, Oncology and Palliative Medicine ; Humans ; Klinisk medisinske fag: 750 ; Medical disciplines: 700 ; Medical prognosis ; Medisinske Fag: 700 ; Mesenchyme ; Metabolism ; Metabolites ; Metabolomics ; Metastases ; Metastasis ; Morphogenesis ; Nodes ; Oncology: 762 ; Onkologi: 762 ; Oxidation ; Peroxisome proliferator-activated receptors ; Transcription factors ; VDP</subject><ispartof>Cancer letters, 2017-06, Vol.396, p.117-129</ispartof><rights>The Author(s)</rights><rights>2017 The Author(s)</rights><rights>Copyright © 2017 The Author(s). Published by Elsevier B.V. All rights reserved.</rights><rights>Copyright Elsevier Limited Jun 28, 2017</rights><rights>info:eu-repo/semantics/openAccess</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c581t-870fdb70165f5c2d79db01b7667cacc8bf63e1747a4978784ab9658f6292865a3</citedby><cites>FETCH-LOGICAL-c581t-870fdb70165f5c2d79db01b7667cacc8bf63e1747a4978784ab9658f6292865a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.canlet.2017.03.019$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,3536,26546,27903,27904,45974</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28323032$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Halldorsson, Skarphedinn</creatorcontrib><creatorcontrib>Rohatgi, Neha</creatorcontrib><creatorcontrib>Magnusdottir, Manuela</creatorcontrib><creatorcontrib>Choudhary, Kumari Sonal</creatorcontrib><creatorcontrib>Guðjónsson, Thorarinn</creatorcontrib><creatorcontrib>Knutsen, Erik</creatorcontrib><creatorcontrib>Barkovskaya, Anna</creatorcontrib><creatorcontrib>Hilmarsdottir, Bylgja</creatorcontrib><creatorcontrib>Perander, Maria</creatorcontrib><creatorcontrib>Mælandsmo, Gunhild M</creatorcontrib><creatorcontrib>Gudmundsson, Steinn</creatorcontrib><creatorcontrib>Rolfsson, Óttar</creatorcontrib><title>Metabolic re-wiring of isogenic breast epithelial cell lines following epithelial to mesenchymal transition</title><title>Cancer letters</title><addtitle>Cancer Lett</addtitle><description>Abstract Epithelial to mesenchymal transition (EMT) has implications in tumor progression and metastasis. Metabolic alterations have been described in cancer development but studies focused on the metabolic re-wiring that takes place during EMT are still limited. We performed metabolomics profiling of a breast epithelial cell line and its EMT derived mesenchymal phenotype to create genome-scale metabolic models descriptive of both cell lines. Glycolysis and OXPHOS were higher in the epithelial phenotype while amino acid anaplerosis and fatty acid oxidation fueled the mesenchymal phenotype. Through comparative bioinformatics analysis, PPAR-γ1, PPAR- γ2 and AP-1 were found to be the most influential transcription factors associated with metabolic re-wiring. In silico gene essentiality analysis predicts that the LAT1 neutral amino acid transporter is essential for mesenchymal cell survival. Our results define metabolic traits that distinguish an EMT derived mesenchymal cell line from its epithelial progenitor and may have implications in cancer progression and metastasis. Furthermore, the tools presented here can aid in identifying critical metabolic nodes that may serve as therapeutic targets aiming to prevent EMT and inhibit metastatic dissemination.</description><subject>Activator protein 1</subject><subject>Amino acids</subject><subject>Bioinformatics</subject><subject>Biomarkers</subject><subject>Breast - metabolism</subject><subject>Breast - pathology</subject><subject>Breast cancer</subject><subject>Breast Neoplasms - genetics</subject><subject>Breast Neoplasms - metabolism</subject><subject>Breast Neoplasms - pathology</subject><subject>Cancer</subject><subject>Cell adhesion &amp; migration</subject><subject>Cell culture</subject><subject>Cell survival</subject><subject>Clinical medical disciplines: 750</subject><subject>EMT</subject><subject>Epithelial Cells - metabolism</subject><subject>Epithelial Cells - pathology</subject><subject>Epithelial-Mesenchymal Transition</subject><subject>Female</subject><subject>Genome scale models</subject><subject>Genomes</subject><subject>Genotype &amp; phenotype</subject><subject>Glycolysis</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Humans</subject><subject>Klinisk medisinske fag: 750</subject><subject>Medical disciplines: 700</subject><subject>Medical prognosis</subject><subject>Medisinske Fag: 700</subject><subject>Mesenchyme</subject><subject>Metabolism</subject><subject>Metabolites</subject><subject>Metabolomics</subject><subject>Metastases</subject><subject>Metastasis</subject><subject>Morphogenesis</subject><subject>Nodes</subject><subject>Oncology: 762</subject><subject>Onkologi: 762</subject><subject>Oxidation</subject><subject>Peroxisome proliferator-activated receptors</subject><subject>Transcription factors</subject><subject>VDP</subject><issn>0304-3835</issn><issn>1872-7980</issn><issn>1872-7980</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>3HK</sourceid><recordid>eNqFksFu1DAQhi0EotvCGyCIxIVLwthOYueChCooSEUcgLPlOJPWW8debC_Vvj2OtgXUCyfL9jfzz8w_hLyg0FCg_dttY7R3mBsGVDTAG6DDI7KhUrBaDBIekw1waGsueXdCTlPaAkDXiu4pOWGSMw6cbcjNF8x6DM6aKmJ9a6P1V1WYK5vCFfryOkbUKVe4s_kandWuMuhc5azHVM3BuXC7hvzzn0O1YEJvrg_Leo3aJ5tt8M_Ik1m7hM_vzjPy4-OH7-ef6suvF5_P31_WppM011LAPI2i9NjNnWGTGKYR6Cj6XhhtjBznniMVrdDtIKSQrR6HvpNzzwYm-07zM_LqmNdEm7L1yoeoFQXgQlHeSijEmyOxi-HnHlNWi01rX9pj2CdVhjj0PeUdL-jrB-g27KMv9RdKSsqYaIdCtfeSIaWIs9pFu-h4KLJqtUtt1dEutdqlgKtiVwl7eZd8Py44_Qm696cA744Alnn9shhVMraMFicb0WQ1Bfs_hYcJTLHOGu1u8IDpby8qMQXq27oy68ZQwYHKUsNvhui7yg</recordid><startdate>20170628</startdate><enddate>20170628</enddate><creator>Halldorsson, Skarphedinn</creator><creator>Rohatgi, Neha</creator><creator>Magnusdottir, Manuela</creator><creator>Choudhary, Kumari Sonal</creator><creator>Guðjónsson, Thorarinn</creator><creator>Knutsen, Erik</creator><creator>Barkovskaya, Anna</creator><creator>Hilmarsdottir, Bylgja</creator><creator>Perander, Maria</creator><creator>Mælandsmo, Gunhild M</creator><creator>Gudmundsson, Steinn</creator><creator>Rolfsson, Óttar</creator><general>Elsevier B.V</general><general>Elsevier Limited</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><scope>3HK</scope></search><sort><creationdate>20170628</creationdate><title>Metabolic re-wiring of isogenic breast epithelial cell lines following epithelial to mesenchymal transition</title><author>Halldorsson, Skarphedinn ; Rohatgi, Neha ; Magnusdottir, Manuela ; Choudhary, Kumari Sonal ; Guðjónsson, Thorarinn ; Knutsen, Erik ; Barkovskaya, Anna ; Hilmarsdottir, Bylgja ; Perander, Maria ; Mælandsmo, Gunhild M ; Gudmundsson, Steinn ; Rolfsson, Óttar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c581t-870fdb70165f5c2d79db01b7667cacc8bf63e1747a4978784ab9658f6292865a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Activator protein 1</topic><topic>Amino acids</topic><topic>Bioinformatics</topic><topic>Biomarkers</topic><topic>Breast - metabolism</topic><topic>Breast - pathology</topic><topic>Breast cancer</topic><topic>Breast Neoplasms - genetics</topic><topic>Breast Neoplasms - metabolism</topic><topic>Breast Neoplasms - pathology</topic><topic>Cancer</topic><topic>Cell adhesion &amp; migration</topic><topic>Cell culture</topic><topic>Cell survival</topic><topic>Clinical medical disciplines: 750</topic><topic>EMT</topic><topic>Epithelial Cells - metabolism</topic><topic>Epithelial Cells - pathology</topic><topic>Epithelial-Mesenchymal Transition</topic><topic>Female</topic><topic>Genome scale models</topic><topic>Genomes</topic><topic>Genotype &amp; phenotype</topic><topic>Glycolysis</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Humans</topic><topic>Klinisk medisinske fag: 750</topic><topic>Medical disciplines: 700</topic><topic>Medical prognosis</topic><topic>Medisinske Fag: 700</topic><topic>Mesenchyme</topic><topic>Metabolism</topic><topic>Metabolites</topic><topic>Metabolomics</topic><topic>Metastases</topic><topic>Metastasis</topic><topic>Morphogenesis</topic><topic>Nodes</topic><topic>Oncology: 762</topic><topic>Onkologi: 762</topic><topic>Oxidation</topic><topic>Peroxisome proliferator-activated receptors</topic><topic>Transcription factors</topic><topic>VDP</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Halldorsson, Skarphedinn</creatorcontrib><creatorcontrib>Rohatgi, Neha</creatorcontrib><creatorcontrib>Magnusdottir, Manuela</creatorcontrib><creatorcontrib>Choudhary, Kumari Sonal</creatorcontrib><creatorcontrib>Guðjónsson, Thorarinn</creatorcontrib><creatorcontrib>Knutsen, Erik</creatorcontrib><creatorcontrib>Barkovskaya, Anna</creatorcontrib><creatorcontrib>Hilmarsdottir, Bylgja</creatorcontrib><creatorcontrib>Perander, Maria</creatorcontrib><creatorcontrib>Mælandsmo, Gunhild M</creatorcontrib><creatorcontrib>Gudmundsson, Steinn</creatorcontrib><creatorcontrib>Rolfsson, Óttar</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><collection>NORA - Norwegian Open Research Archives</collection><jtitle>Cancer letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Halldorsson, Skarphedinn</au><au>Rohatgi, Neha</au><au>Magnusdottir, Manuela</au><au>Choudhary, Kumari Sonal</au><au>Guðjónsson, Thorarinn</au><au>Knutsen, Erik</au><au>Barkovskaya, Anna</au><au>Hilmarsdottir, Bylgja</au><au>Perander, Maria</au><au>Mælandsmo, Gunhild M</au><au>Gudmundsson, Steinn</au><au>Rolfsson, Óttar</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Metabolic re-wiring of isogenic breast epithelial cell lines following epithelial to mesenchymal transition</atitle><jtitle>Cancer letters</jtitle><addtitle>Cancer Lett</addtitle><date>2017-06-28</date><risdate>2017</risdate><volume>396</volume><spage>117</spage><epage>129</epage><pages>117-129</pages><issn>0304-3835</issn><issn>1872-7980</issn><eissn>1872-7980</eissn><abstract>Abstract Epithelial to mesenchymal transition (EMT) has implications in tumor progression and metastasis. Metabolic alterations have been described in cancer development but studies focused on the metabolic re-wiring that takes place during EMT are still limited. We performed metabolomics profiling of a breast epithelial cell line and its EMT derived mesenchymal phenotype to create genome-scale metabolic models descriptive of both cell lines. Glycolysis and OXPHOS were higher in the epithelial phenotype while amino acid anaplerosis and fatty acid oxidation fueled the mesenchymal phenotype. Through comparative bioinformatics analysis, PPAR-γ1, PPAR- γ2 and AP-1 were found to be the most influential transcription factors associated with metabolic re-wiring. In silico gene essentiality analysis predicts that the LAT1 neutral amino acid transporter is essential for mesenchymal cell survival. Our results define metabolic traits that distinguish an EMT derived mesenchymal cell line from its epithelial progenitor and may have implications in cancer progression and metastasis. Furthermore, the tools presented here can aid in identifying critical metabolic nodes that may serve as therapeutic targets aiming to prevent EMT and inhibit metastatic dissemination.</abstract><cop>Ireland</cop><pub>Elsevier B.V</pub><pmid>28323032</pmid><doi>10.1016/j.canlet.2017.03.019</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0304-3835
ispartof Cancer letters, 2017-06, Vol.396, p.117-129
issn 0304-3835
1872-7980
1872-7980
language eng
recordid cdi_cristin_nora_10037_13480
source MEDLINE; NORA - Norwegian Open Research Archives; Elsevier ScienceDirect Journals Complete
subjects Activator protein 1
Amino acids
Bioinformatics
Biomarkers
Breast - metabolism
Breast - pathology
Breast cancer
Breast Neoplasms - genetics
Breast Neoplasms - metabolism
Breast Neoplasms - pathology
Cancer
Cell adhesion & migration
Cell culture
Cell survival
Clinical medical disciplines: 750
EMT
Epithelial Cells - metabolism
Epithelial Cells - pathology
Epithelial-Mesenchymal Transition
Female
Genome scale models
Genomes
Genotype & phenotype
Glycolysis
Hematology, Oncology and Palliative Medicine
Humans
Klinisk medisinske fag: 750
Medical disciplines: 700
Medical prognosis
Medisinske Fag: 700
Mesenchyme
Metabolism
Metabolites
Metabolomics
Metastases
Metastasis
Morphogenesis
Nodes
Oncology: 762
Onkologi: 762
Oxidation
Peroxisome proliferator-activated receptors
Transcription factors
VDP
title Metabolic re-wiring of isogenic breast epithelial cell lines following epithelial to mesenchymal transition
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T06%3A19%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_crist&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Metabolic%20re-wiring%20of%20isogenic%20breast%20epithelial%20cell%20lines%20following%20epithelial%20to%20mesenchymal%20transition&rft.jtitle=Cancer%20letters&rft.au=Halldorsson,%20Skarphedinn&rft.date=2017-06-28&rft.volume=396&rft.spage=117&rft.epage=129&rft.pages=117-129&rft.issn=0304-3835&rft.eissn=1872-7980&rft_id=info:doi/10.1016/j.canlet.2017.03.019&rft_dat=%3Cproquest_crist%3E1888122749%3C/proquest_crist%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1888122749&rft_id=info:pmid/28323032&rft_els_id=1_s2_0_S0304383517301830&rfr_iscdi=true